Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer’s disease that features clinical information for self-care and drug therapy options, as well as related cost information.
New class of antibody could benefit patients with treatment-resistant cancers
A Cancer Research UK-funded clinical trial has shown, for the first time, that a new class of antibody could benefit cancer patients whose existing treatments